TOKYO, Oct. 8, 2024 /PRNewswire/ — Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, “Ciconia”) today announced its establishment as a joint venture company based on a master agreement signed on April 22, 2024 by Takeda Pharmaceutical Company Limited (TSE:…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.